AstraZeneca-Oxford COVID-19 Vaccine Shows High Efficacy
XTalks
NOVEMBER 23, 2020
Adding to recent announcements from Pfizer and Moderna on the efficacy of their COVID-19 vaccine candidates, AstraZeneca and Oxford revealed today that their vaccine contender is 70 percent effective, and could be as high as 90 percent. Oxford-AstraZeneca COVID-19 Vaccine Induces Immune Responses in Early Clinical Trials.
Let's personalize your content